Association of Adolescent Obesity with Nonalcoholic Fatty Liver Disease and Related Risk Factors in Xi 'an, China.

INTRODUCTION AND AIM To investigate the association of adolescent obesity with nonalcoholic fatty liver disease (NAFLD) and related risk factors in Xi'an, China. MATERIAL AND METHODS A total of 4141 adolescents (2,061 girls and 2,080 boys, mean age: 18.62 ± 0.66 years, age range 15-22 years) were enrolled in this investigation. Anthropometric index was measured, and liver ultrasonography and liver function biochemical test were performed in all the subjects. T test, χ2 test and logistic regression analysis were used for statistical analyses. RESULTS The total rates of obesity was 7.9% (08/4,141). The prevalence rate of NAFLD was 8.1% (335/4141) with a declining trend from obesity, overweight to normal BMI. NAFLD prevalence rate in obese boys was significantly higher than in girls (χ2 = 56.5, P < 0.01). BMI, body weight, ALT, and AST in NAFLD group were higher than in non-NAFLD group (P < 0.05). The tangent point of ALT was 36 U/L using Youden index in boys, and 33 U/L in girls. CONCLUSION The prevalence of obesity and NAFLD in adolescents is higher in Xi'an than anticipated. Body weight and BMI may be the associated independent risk factors of NAFLD.

[1]  R. Hultcrantz,et al.  Overweight in late adolescence predicts development of severe liver disease later in life: A 39years follow-up study. , 2016, Journal of hepatology.

[2]  D. Lawlor,et al.  Nonalcoholic Fatty Liver Disease, Liver Fibrosis, and Cardiometabolic Risk Factors in Adolescence: A Cross-Sectional Study of 1874 General Population Adolescents , 2014, The Journal of clinical endocrinology and metabolism.

[3]  A. Sanyal,et al.  Association between high-normal levels of alanine aminotransferase and risk factors for atherogenesis. , 2013, Gastroenterology.

[4]  V. Giorgio,et al.  Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets , 2013, BMC Pediatrics.

[5]  P. Schwingel,et al.  Hormone replacement therapy in menopausal women: risk factor or protection to nonalcoholic fatty liver disease? , 2012, Annals of hepatology.

[6]  中华医学会内分泌学分会肥胖学组 中国成人肥胖症防治专家共识 , 2011 .

[7]  M. Stepanova,et al.  Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[8]  C. Day Non-alcoholic fatty liver disease: a massive problem. , 2011, Clinical medicine.

[9]  D. Spruijt-Metz Etiology, Treatment and Prevention of Obesity in Childhood and Adolescence: A Decade in Review. , 2011, Journal of research on adolescence : the official journal of the Society for Research on Adolescence.

[10]  J. Lavine,et al.  Nonalcoholic fatty liver disease in children , 2010, Current opinion in clinical nutrition and metabolic care.

[11]  C. Bouchard,et al.  The association between sleep duration and weight gain in adults: a 6-year prospective study from the Quebec Family Study. , 2008, Sleep.

[12]  A. Zanella,et al.  Updated Definitions of Healthy Ranges for Serum Alanine Aminotransferase Levels , 2002, Annals of Internal Medicine.